The National Development and Reform Commission holds a training meeting for pharmaceutical companies to revise relevant regulations on drug ex-factory price surveys

Source: the drug price review center of the national development and Reform Commission issued a notice on June 5, 2014, and will hold a training meeting on drug price review enterprises on June 12 and 13, to carry out training on drug cost investigation, ex factory price investigation process, requirements and related review work, focusing on improving the quality and efficiency of drug cost price investigation According to the list of enterprises participating in the training conference issued by the national development and Reform Commission, there are more than 100 enterprises participating in the conference, including listed companies such as Kangenbei (600572 SH), Asia Pacific Pharmaceutical (002370 SZ), Wuhan Jianmin (600976 SH), Hansen Pharmaceutical (002412 SZ), etc Drug cost investigation is the basis and standard for the development and Reform Commission to formulate drug prices, but the progress of cost investigation has been slow, which has seriously hindered the progress of pricing work In the past two years, the national development and Reform Commission has repeatedly urged pharmaceutical companies to report cost prices, according to the website of the drug price review center The drug price evaluation center just held a collective discussion meeting last month It plans to modify the current drug cost and ex factory price investigation methods and specifications, and further improve the evaluation system.